Observational Cohort Study of Lasmiditan Exposure and Motor Vehicle Accidents in the United States (MI DRIVE) H8H-MC-B006

24/10/2024
20/11/2024
EU PAS number:
EUPAS1000000347
Study
Planned
Study type

Study topic

Human medicinal product

Study type

Non-interventional study

Scope of the study

Other

If ‘other’, further details on the scope of the study

Safety in operating heavy machinery

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Cohort
Study drug and medical condition

Medicinal product name

RAYVOW

Study drug International non-proprietary name (INN) or common name

LASMIDITAN

Anatomical Therapeutic Chemical (ATC) code

(N02CC08) lasmiditan
lasmiditan

Medical condition to be studied

Migraine